Rainer,
Welcome back,
As I write this, I see we've broken below the $6.50 threshhold, where there wasn't any support. I'm going to wait for your buying signal before I get more, which I believe was over $8.30, a point never reached last week. I for one was surprised at the lack of support below $7. Even though the recent report wasn't great, as many have pointed out, it wasn't surprising. Even so, bad news is bad news. now the concern is how long it will take to get FDA approval vs. how long the cash holds out.
Considering the strength of the SNRS team working the FDA, I'm surprised at the weakness of the marketing effort. Perhaps they were on hold until FDA approval.
I make no predictions on downside. I hope to see some strong support soon, or we're in for a rough, unpleasant ride.
Regards,
Sylvester |
